Showing results (61-70 of 136) with videos related to
Sort By:
Pageof 14
Small (Weinheim an Der Bergstrasse, Germany)|April 3, 2023
Dithieno[3,2-f:2',3'-h]quinoxaline-Based Photovoltaic-Thermoelectric Dual-Functional Energy-Harvesting Wide-Bandgap Polymer and its Backbone IsomerSeong-Jun Yoon, Kang Suh Choi, Lian Zhong, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 27, 2019
Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progressionJunhun Cho, Seok Jin Kim, Woong-Yang Park, et al.Journal of Oncology|October 6, 2022
Survival Outcomes of Patients with Follicular Lymphoma after Relapse or Progression: A Single-Center Real-World Data AnalysisYong-Pyo Lee, Min-Sang Lee, Sang Eun Yoon, et al.Cancer Research and Treatment|August 20, 2024
Clinical Impact of Microbiome Characteristics in Treatment-Naïve Extranodal NK/T-Cell Lymphoma PatientsSang Eun Yoon, Woorim Kang, Junhun Cho, et al.Journal of Cancer Survivorship : Research and Practice|May 16, 2025
Cardiovascular disease in adolescent and young adult survivors of non-Hodgkin lymphoma in KoreaKeun Hye Jeon, Danbee Kang, Dong Wook Shin, et al.Seminars in Oncology Nursing|May 1, 2025
Different Level and Difficulties with Financial Burden in Multiple Myeloma Patients and Caregivers: A Dyadic Qualitative StudyYoungJu Park, Sooyeon Kim, Nayeon Kim, et al.Annals of Hematology|April 17, 2020
Plasma cell-free DNA is a prognostic biomarker for survival in patients with aggressive non-Hodgkin lymphomasJoon Young Hur, Yeon Jeong Kim, Sang Eun Yoon, et al.Annals of Hematology|May 10, 2024
Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphomaSang Eun Yoon, Hyungwoo Cho, Philipp Berning, et al.Korean Circulation Journal|December 10, 2025
Real-World Efficacy of Tafamidis in Korean ATTR-CM Patients: A Retrospective Observational Strain AnalysisHeayoung Shin, Kina Jeon, Darae Kim, et al.Journal of Cancer|April 15, 2021
Exosomal miR-1305 in the oncogenic activity of hypoxic multiple myeloma cells: a biomarker for predicting prognosisJi Young Lee, Daeun Ryu, Sung Won Lim, et al.Pageof 14